The vaccine for varicella (chicken pox) has been approved and is available. It is a live, attenuated vaccine called Varivax, and is manufactured by Merck. Varivax is indicated for use in individuals 12 months of age and older. The duration of protection is unknown, hence the need for revaccination is not defined.